Royalty Pharma plc (FRA:RPD)
Germany
· Delayed Price · Currency is EUR 31.04
+0.05 (0.16%)
At close: Aug 15, 2025, 10:00 PM CET
Royalty Pharma Revenue
Royalty Pharma had revenue of $578.67M USD in the quarter ending June 30, 2025, with 7.71% growth. This brings the company's revenue in the last twelve months to $2.31B, up 3.02% year-over-year. In the year 2024, Royalty Pharma had annual revenue of $2.26B, down -3.86%.
Revenue (ttm)
$2.31B
Revenue Growth
+3.02%
P/S Ratio
6.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.42B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Energy AG | 38.39B |
| Rheinmetall AG | 10.67B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Deutsche Bank Aktiengesellschaft | 30.07B |